Purple Biotech Ltd (KTOV) — Financial Flexibility Index

Latest as of June 2020: -0.08x

Purple Biotech Ltd (KTOV) has a Financial Flexibility Index of -0.08x as of June 2020. Free cash flow of ILA-2.32 Million (operating CF ILA-2.32 Million minus capex ILA0.00) represents 0% of total liabilities (ILA29.64 Million). Check Purple Biotech Ltd (KTOV) tangible net worth to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-0.08x
Free Cash Flow / Total Liabilities

Free Cash Flow

ILA-2.32 Million
Operating CF − Capex

Total Liabilities

ILA29.64 Million
ILA

Capital Expenditures

ILA0.00
ILA

Purple Biotech Ltd Financial Flexibility Index (2013–2019)

Historical Financial Flexibility Index trend for Purple Biotech Ltd across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Purple Biotech Ltd.

Annual Financial Flexibility Index for Purple Biotech Ltd (2013–2019)

Year-by-year free cash flow to debt coverage for Purple Biotech Ltd. Explore KTOV operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (ILA) Operating CF Total Liabilities YoY Change
2019 -1.44x ILA-5.57 Million ILA-5.58 Million ILA3.86 Million ▲ +36.6%
2018 -2.28x ILA-8.46 Million ILA-8.48 Million ILA3.72 Million ▼ -47.7%
2017 -1.54x ILA-8.61 Million ILA-8.63 Million ILA5.59 Million ▲ +62.3%
2016 -4.09x ILA-6.25 Million ILA-6.26 Million ILA1.53 Million ▼ -71.4%
2015 -2.39x ILA-3.30 Million ILA-3.31 Million ILA1.38 Million ▲ +52.0%
2014 -4.97x ILA-4.52 Million ILA-4.53 Million ILA908.00K ▼ -1143.2%
2013 -0.40x ILA-503.00K ILA-512.00K ILA1.26 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities